Skip to main content
Premium Trial:

Request an Annual Quote

Promega Provides ATCC Access to Labeling Technologies

NEW YORK (GenomeWeb News) – ATCC on Thursday announced a non-exclusive licensing deal to develop, receive, and distribute biological materials containing Promega's labeling technologies.

The materials from ATCC will contain Promega's NanoLuc, GloSensor, and HaloTag technologies, and the deal covers new and existing products.

"Through this trio of new technologies, ATCC is now better able to [access], develop, and distribute novel products, and deliver new services, which will drive biological research," Brian Pollok, president of ATCC, said in a statement.

NanoLuc is an ATP-independent luciferase that uses a novel coelenterazine analog to produce high intensity, glow-type luminescence. GloSensor uses bioluminescence for the intracellular detection of signal transduction in living cells, and HaloTag, based on the formation of a covalent bond between a protein tag and synthetic ligands, enables the understanding of protein functions in a cellular and biochemical environment, ATCC said.

Financial and other terms of the deal were not disclosed.

Last year, the companies collaborated on cell banking and the bioproduction of cells for the creation of bioluminescence-based drug discovery assays for biologics.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.